The other goals of the study were similarly reached when it was shown the keratin 6a was expressed in tumor heterotransplants generated from the Cd2+- and As3+-transformed cells and that keratin 6a was overexpressed in some archival patient specimens of high-grade bladder cancer. This evidence concerns the gene CD2 and neoplasm.